EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Repurposing Cardiac Glycosides to Potentiate CD47 Blockade through Calreticulin‐mediated Phagocytic Effects for Lung Cancer Treatment

Zi-Han Ye, Wei-Bang Yu, Mu-Yang Huang, Yan-Yan Chen, Le-Le Zhang, Chung-Hang Leung, Xiao-Lei Zhang, Zhenghai Tang, Ting Li, Jin-Jian Lu iD

Advanced Science · 2025-12 · 12 (46)

DOI: 10.1002/advs.202508245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 23.09.2025. Verfasst von Zi-Han Ye und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, 999078, China. Hauptthemen laut MEDLINE: CD47 Antigen, Lung Neoplasms, Calreticulin, Phagocytosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Development Fund, Macau SAR, University of Macau, Universidade de Macau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The abundance of macrophages within the tumor microenvironment (TME) of lung cancer represents a noteworthy therapeutic target. Exploiting the phagocytic function of macrophages by blocking the “don't eat me” signal, CD47, has shown significant therapeutic potential. However, novel CD47‐targeted combination strategies warrant further investigation. Through an analysis of data obtained from a screening model focused on the macrophage‐mediated killing effect, two cardiac glycosides (CGs), ouabain and digoxin, are shown to increase the capacity of macrophages to kill cancer cells after combination with CD47 antibody. Compared with the control, the combination strategy reduced the tumor volume in different lung cancer models and increased the macrophage phagocytosis rate ≈5‐fold. Mechanistically, in addition to Fc‐FcγR interaction, CGs enhanced the expression of a pro‐phagocytotic signal, calreticulin (CRT). Moreover, PERK inhibitor, ER‐Golgi protein trafficking inhibitor, and siRNA‐mediated knockdown of exocytosis protein exo70, abrogated both CGs‐induced CRT upregulation and the ensuing enhancement of phagocytosis. These findings indicate that CGs drive CRT translocation originates from ER to Golgi apparatus, where it subsequently anchors to the cell surface via exo70‐mediated exocytosis. Overall, this study offers compelling evidence that supports the clinical translation of an innovative combination regimen for the treatment of patients with lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD47 AntigenLung NeoplasmsCalreticulinPhagocytosisCardiac GlycosidesAnimalsHumansMiceMacrophagesCell Line, TumorDrug RepositioningTumor MicroenvironmentDigoxinOuabain

Stichwörter der Autor:innen

CD47 blockadecalreticulincardiac glycosideslung cancerphagocytosis

Substanzen

CD47 AntigenCalreticulinCardiac GlycosidesDigoxinCD47 protein, humanOuabain

Autor:innen und Institutionen

  • State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, 999078, China.
  • School of Basic Medical Sciences, Chengdu University, Chengdu, 610106, China.
  • National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou,…
  • Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Macao, 999078, China.
  • MoE Frontiers Science Center for Precision Oncology, University of Macau, Macao, 999078, China.
  • Department of Pharmaceutical Sciences, Faculty of Health Sciences, University of Macau, Macao, 999078, China.

ORCID-Profile: Jin-Jian Lu

Förderung

  • Science and Technology Development Fund, Macau SAR
  • University of Macau
  • Universidade de Macau

Zitieren

APA

Ye, Z. H., Yu, W. B., Huang, M. Y., Chen, Y. Y., Zhang, L. L., Leung, C. H., Zhang, X. L., Tang, Z., Li, T., & Lu, J. J. (2025). Repurposing Cardiac Glycosides to Potentiate CD47 Blockade through Calreticulin‐mediated Phagocytic Effects for Lung Cancer Treatment. Advanced Science, 12(46). https://doi.org/10.1002/advs.202508245

Vancouver

Ye ZH, Yu WB, Huang MY, Chen YY, Zhang LL, Leung CH, et al. Repurposing Cardiac Glycosides to Potentiate CD47 Blockade through Calreticulin‐mediated Phagocytic Effects for Lung Cancer Treatment. Advanced Science. 2025;12(46). doi:10.1002/advs.202508245

BibTeX
@article{Ye2025,
  author = {Ye, Zi-Han and Yu, Wei-Bang and Huang, Mu-Yang and Chen, Yan-Yan and Zhang, Le-Le and Leung, Chung-Hang and Zhang, Xiao-Lei and Tang, Zhenghai and Li, Ting and Lu, Jin-Jian},
  title = {Repurposing Cardiac Glycosides to Potentiate CD47 Blockade through Calreticulin‐mediated Phagocytic Effects for Lung Cancer Treatment},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {46},
  doi = {10.1002/advs.202508245}
}
Kostenlos starten →